AGREEMENT AND PLAN OF MERGERMerger Agreement • January 19th, 2022 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
This AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of January 14, 2022, is among Sorrento Therapeutics, Inc., a Delaware corporation (the “Parent”), VH Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), VH Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of Parent (“Merger LLC”), Virex Health, Inc., a Delaware corporation (the “Company”), and Fortis Advisors LLC, a Delaware limited liability company, as the Stockholders’ Representative (as defined in Section 10.14(a); and collectively with Parent, Merger Sub, Merger LLC and Company, the “Parties”).
